
Sign up to save your podcasts
Or
We love to hear from our listeners. Send us a message.
When it comes to manufacturing, many cell and gene therapy companies struggle to automate the diverse processes needed to scale manufacturing. London-based PA Consulting's Associate Partner, Paolo Siciliano, talks to Cell & Gene: The Podcast's Erin Harris about how lean, small biotechs with limited resources and limited funds can strive for automation success. They also discuss what cell and gene therapy companies should do today to address tomorrow’s scalability challenges and what the long-term effects on the business may be from such upfront work.
Subscribe to the podcast!
Apple | Spotify | YouTube
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
When it comes to manufacturing, many cell and gene therapy companies struggle to automate the diverse processes needed to scale manufacturing. London-based PA Consulting's Associate Partner, Paolo Siciliano, talks to Cell & Gene: The Podcast's Erin Harris about how lean, small biotechs with limited resources and limited funds can strive for automation success. They also discuss what cell and gene therapy companies should do today to address tomorrow’s scalability challenges and what the long-term effects on the business may be from such upfront work.
Subscribe to the podcast!
Apple | Spotify | YouTube
763 Listeners
808 Listeners
4,245 Listeners
32,055 Listeners
124 Listeners
271 Listeners
318 Listeners
699 Listeners
88 Listeners
31 Listeners
146 Listeners
11 Listeners
15 Listeners
149 Listeners
47 Listeners